Monday, Sep 28, 2026

"dr-reddys-laboratories"

Russian vaccine arrives in India for human clinical trial

The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.
Dr Reddy’s partners with BIRAC for Sputnik V vaccine trials in India

Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres
Dr Reddy’s detects cyber-attack, isolates its data centre services

Says it anticipates all services to be up within 24 hours and do not foresees any major impact on its operations
Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine

This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
Dr Reddy’s joins global initiative to reduce carbon emissions

The company has committed to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 55 per cent by 2030 from a FY2017-18 base year.